Andrew John Partridge

Insider Reports History

Location
Boston, MA
Signature
/s/ Paolo Tombesi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew John Partridge:

Company Role Class Num Shares Value Price $ Report Date Ownership
Turning Point Therapeutics, Inc. EVP & Chief Commercial Officer Common Stock 38,361 $2,915,436 $76.00 09 Feb 2022 Direct
Turning Point Therapeutics, Inc. EVP & Chief Commercial Officer Stock Option (right to buy) 58,600 09 Feb 2022 Direct

Insider Reports Filed by Andrew John Partridge

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TPTX Turning Point Therapeutics, Inc. 09 Feb 2022 3 -$8,022 4 EVP & Chief Commercial Officer 11 Feb 2022, 17:09
TPTX Turning Point Therapeutics, Inc. 14 Jul 2021 1 -$139,988 4 EVP & Chief Commercial Officer 15 Jul 2021, 17:53